Why Don't Some People With Asthma Respond to Medication?
All asthma is not the same. As a result, a new study shows many people with asthma are not helped by corticosteroid medication prescribed to...
All asthma is not the same. As a result, a new study shows many people with asthma are not helped by corticosteroid medication prescribed to...
AstraZeneca Plc. (AZN) is one of the world's largest pharmaceutical companies. Headquartered in England, it is the result of a merger between...
AstraZeneca PLC (AZN) is a leading global pharmaceutical company with a strong track record of paying dividends. AZN's estimated forward dividend...
Courtesy of Pharmboy of Phil's Stock World . . Theravance (THRX) is a biopharmaceutical company that is involved in discovering, developing and...
Drug maker AstraZeneca PLC faces a delay in marketing its asthma treatment Symbicort for young children in the United States after regulators on Monday requested more information about the drug.The use of Symbicort for the long-term maintenance treatment of asthma is ...
Advair OK, but some long-acting asthma medications too risky for useGovernment health advisers recommended restrictions Thursday on some long-acting asthma drugs, although not Advair, a top-selling medication.Outside experts advising the Food and Drug Administration said Foradil and Serevent no longer should ...
GlaxoSmithKline PLC is cutting jobs as part of a major cost-savings plan following a sharp drop in sales of its diabetes drug and increasing generic competition in the United States that led to a 5.8 percent drop in quarterly profits.Glaxo ...
GlaxoSmithKline PLC reported a 5.8 percent drop in third-quarter net profit on Wednesday after a slump in sales of its troubled diabetes drug Avandia and increasing generic competition to its established medicines in the Unites States.Glaxo, the world's second-largest ...
AstraZeneca PLC said it will more than double previously planned job cuts as it reported Thursday that quarterly profit fell 12.5 percent.AstraZeneca, Britain's second-largest drugmaker behind GlaxoSmithKline PLC, said it will eliminate around 7,600 positions, or 11 percent ...